Expert Answers to Questions on Managing Neurofibromatosis Type 1 and MEK Inhibitors for NF1-Associated Plexiform Neurofibromas

Decera Clinical Education Oncology Podcast · Jul 12, 2021 · 13m

In this episode, Scott R. Plotkin, MD, PhD, and Brian D. Weiss, MD, answer questions from a healthcare professional audience on topics related to NF1 and plexiform neurofibromas including:

Whole exome sequencing for diagnosis

When to treat asymptomatic tumors

Genetic testing of family members

Choosing a MEK inhibitor

Supportive care for acneiform rash

Other RAS pathway inhibitors

Presenters:

Scott R. Plotkin, MD, PhD

Executive Director

Pappas Center for Neuro-Oncology

Professor of Neurology

Harvard Medical School

Boston, Massachusetts

Brian D. Weiss, MD

Clinical Professor of Pediatrics

Cancer…